List of Global Blood Therapeutics patents

Patent 10034879 was granted and assigned to Global Blood Therapeutics on July, 2018 by the United States Patent and Trademark Office.

Patent 10017491 was granted and assigned to Global Blood Therapeutics on July, 2018 by the United States Patent and Trademark Office.

Patent 10137118 was granted and assigned to Global Blood Therapeutics on November, 2018 by the United States Patent and Trademark Office.

Patent 10450269 was granted and assigned to Global Blood Therapeutics on October, 2019 by the United States Patent and Trademark Office.

Patent 10493035 was granted and assigned to Global Blood Therapeutics on December, 2019 by the United States Patent and Trademark Office.

Patent 11548880 was granted and assigned to Global Blood Therapeutics on January, 2023 by the United States Patent and Trademark Office.

Patent 10077249 was granted and assigned to Global Blood Therapeutics on September, 2018 by the United States Patent and Trademark Office.

Patent 10435393 was granted and assigned to Global Blood Therapeutics on October, 2019 by the United States Patent and Trademark Office.

Patent 10683285 was granted and assigned to Global Blood Therapeutics on June, 2020 by the United States Patent and Trademark Office.

Patent 10315991 was granted and assigned to Global Blood Therapeutics on June, 2019 by the United States Patent and Trademark Office.

Patent 11254651 was granted and assigned to Global Blood Therapeutics on February, 2022 by the United States Patent and Trademark Office.

Patent 10100040 was granted and assigned to Global Blood Therapeutics on October, 2018 by the United States Patent and Trademark Office.

Patent 11020382 was granted and assigned to Global Blood Therapeutics on June, 2021 by the United States Patent and Trademark Office.

Patent 9447071 was granted and assigned to Global Blood Therapeutics on September, 2016 by the United States Patent and Trademark Office.

Patent 9981939 was granted and assigned to Global Blood Therapeutics on May, 2018 by the United States Patent and Trademark Office.

Patent 9458139 was granted and assigned to Global Blood Therapeutics on October, 2016 by the United States Patent and Trademark Office.

Patent 9604999 was granted and assigned to Global Blood Therapeutics on March, 2017 by the United States Patent and Trademark Office.

Patent 10004725 was granted and assigned to Global Blood Therapeutics on June, 2018 by the United States Patent and Trademark Office.

Patent 11530191 was granted and assigned to Global Blood Therapeutics on December, 2022 by the United States Patent and Trademark Office.

Patent 8952171 was granted and assigned to Global Blood Therapeutics on February, 2015 by the United States Patent and Trademark Office.

Patent 9422279 was granted and assigned to Global Blood Therapeutics on August, 2016 by the United States Patent and Trademark Office.

Patent 9957250 was granted and assigned to Global Blood Therapeutics on May, 2018 by the United States Patent and Trademark Office.

Patent 9776960 was granted and assigned to Global Blood Therapeutics on October, 2017 by the United States Patent and Trademark Office.

Patent 9248199 was granted and assigned to Global Blood Therapeutics on February, 2016 by the United States Patent and Trademark Office.

Patent 10577345 was granted and assigned to Global Blood Therapeutics on March, 2020 by the United States Patent and Trademark Office.